Post-mortem analyses of PiB and flutemetamol in diffuse and cored amyloid-β plaques in Alzheimer’s disease

Abnormal Amyloid Load in Mild Cognitive Impairment: The Effect of Reducing the PiB‐PET Threshold

(2019) Rola Ismail et al.   JOURNAL OF NEUROIMAGING

Staging β-Amyloid Pathology With Amyloid Positron Emission Tomography

(2019) Niklas Mattsson et al.   JAMA Neurology

Infrequent false positive [18F]flutemetamol PET signal is resolved by combined histological assessment of neuritic and diffuse plaques

(2018) Milos D. Ikonomovic et al.   Alzheimers Research & Therapy

Comparison of longitudinal Aβ in non-demented elderly and Down syndrome

(2018) Dana L. Tudorascu et al.   NEUROBIOLOGY OF AGING

Centiloid scaling for quantification of brain amyloid with [18F]flutemetamol using multiple processing methods

(2018) Mark R. Battle et al.   EJNMMI Research

Imaging the ageing brain: identifying early disease or opening Pandora's box?

(2017) Jonathan M Schott   LANCET NEUROLOGY

Harvard Aging Brain Study: Dataset and accessibility

(2017) Alexander Dagley et al.   NEUROIMAGE

In vivo staging of regional amyloid deposition

(2017) Michel J. Grothe et al.   NEUROLOGY

Small-molecule PET Tracers for Imaging Proteinopathies

(2017) Chester A. Mathis et al.   SEMINARS IN NUCLEAR MEDICINE

Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria

(2016) Bruno Dubois et al.   Alzheimers & Dementia

Detection of Striatal Amyloid Plaques with [18F]flutemetamol: Validation with Postmortem Histopathology

(2016) Thomas G. Beach et al.   JOURNAL OF ALZHEIMERS DISEASE

Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: Phase 3 study

(2015) Osama Sabri et al.   Alzheimers & Dementia

Clinicopathologic and11C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer’s disease spectrum

(2015) Melissa E. Murray et al.   BRAIN

Amyloid β Accumulation Assessed with 11C-Pittsburgh Compound B PET and Postmortem Neuropathology

(2015) Hiroyuki Hatsuta et al.   Current Alzheimer Research

Changes in Aβ biomarkers and associations with APOE genotype in 2 longitudinal cohorts

(2015) Susan M. Resnick et al.   NEUROBIOLOGY OF AGING

Phase 3 Trial of Flutemetamol Labeled With Radioactive Fluorine 18 Imaging and Neuritic Plaque Density

(2015) Craig Curtis et al.   JAMA Neurology

Regional analysis of striatal and cortical amyloid deposition in patients with Alzheimer's disease

(2014) Kenji Ishibashi et al.   EUROPEAN JOURNAL OF NEUROSCIENCE

National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease

(2012) Bradley T. Hyman et al.   Alzheimers & Dementia

Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study

(2012) Christopher M Clark et al.   LANCET NEUROLOGY

Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease

(2012) Randall J. Bateman et al.   NEW ENGLAND JOURNAL OF MEDICINE

National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach

(2011) Thomas J. Montine et al.   ACTA NEUROPATHOLOGICA

Use of Florbetapir-PET for Imaging β-Amyloid Pathology

(2011) Christopher M. Clark   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study

(2011) Henryk Barthel et al.   LANCET NEUROLOGY

18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: A phase 2 trial

(2010) Rik Vandenberghe et al.   ANNALS OF NEUROLOGY

In Vivo Imaging of Amyloid Deposition in Alzheimer Disease Using the Radioligand 18F-AV-45 (Flobetapir F 18)

(2010) D. F. Wong et al.   JOURNAL OF NUCLEAR MEDICINE

High Striatal Amyloid β-Peptide Deposition Across Different Autosomal Alzheimer Disease Mutation Types

(2009) Victor L. Villemagne et al.   ARCHIVES OF NEUROLOGY

The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease

(2009) Kathryn A Ellis et al.   INTERNATIONAL PSYCHOGERIATRICS

Phase 1 Study of the Pittsburgh Compound B Derivative 18F-Flutemetamol in Healthy Volunteers and Patients with Probable Alzheimer Disease

(2009) N. Nelissen et al.   JOURNAL OF NUCLEAR MEDICINE

PET amyloid ligand [11C]PIB uptake shows predominantly striatal increase in variant Alzheimer's disease

(2008) J. Koivunen et al.   BRAIN

Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease

(2008) Milos D. Ikonomovic et al.   BRAIN

The Mayo Clinic Study of Aging: Design and Sampling, Participation, Baseline Measures and Sample Characteristics

(2008) Rosebud O. Roberts et al.   NEUROEPIDEMIOLOGY